A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
Abstract Our aim was to clarify the optimum pre-ablative thyroid-stimulating hormone (TSH) level for initial radioiodine remnant ablation (RRA) in patients with differentiated thyroid carcinoma (DTC). From December 2015 to May 2019, 689 patients undergone RRA at Nuclear Medicine Department, Second H...
Saved in:
Main Authors: | Juan Xiao, Canhua Yun, Jingjia Cao, Shouluan Ding, Chunchun Shao, Lina Wang, Fengyan Huang, Hongying Jia |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d79ca3e2c7a54b23b2de6ae6513254e9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
by: Bernadette Biondi, et al.
Published: (2008) -
Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.
by: Hanna O Mäenpää, et al.
Published: (2008) -
Oxidative stress and radioiodine treatment of differentiated thyroid cancer
by: Angelika Buczyńska, et al.
Published: (2021) -
Minimally Invasive Radiofrequency Ablation for Large Thyroid Toxic Adenoma
by: Belitova M., et al.
Published: (2019) -
Efficacy on radiofrequency ablation according to the types of benign thyroid nodules
by: Jianhua Li, et al.
Published: (2021)